Key result
Among COVID-19 patients presenting to the emergency department with chest pain, the most common causes were musculoskeletal (39.2%), respiratory (23.5%), and cardiovascular (20.6%).
Why the study?
COVID-19 contributes to serious cardiovascular complications, prompting an evaluation of the causes of chest pain and cardiovascular effects in emergency department patients with COVID-19.
Observational (n=102)
No
In COVID-19 patients presenting with chest pain, while musculoskeletal causes are most common, cardiovascular pathologies account for approximately 20% of cases and should be carefully evaluated.
May inform cardiac evaluation in COVID-19 chest pain; leaves open prospective validation of troponin thresholds.
Aim: Chest pain is one of the most common complaints of patients in the emergency departments during the pandemic and non-pandemic period. Because the cause of chest pain can range, from an ordinary, harmless muscle pull to serious cardiac complication ultimately leading to cardiac arrest. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through angiotensin converting enzyme 2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, and also causing acute cardiac injury and chronic damage to the cardiovascular system. COVID-19 contributes to the development of serious cardiovascular complications such as acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest. In this study, it was aimed to determine the effects of COVID-19 on the cardiovascular system by evaluating the causes of chest pain in COVID-19 patients who applied to the emergency department with chest pain. Methods: This retrospective study was conducted by examining the files of COVID-19 patients who applied to a district emergency department with chest pain. Results: The files of 102 COVID-19 patients were reviewed. The most common causes of CP were musculoskeletal system (39.2%), respiratory system (23.5%), CVS diseases (20.6%), idiopathic causes (8.8%), gastrointestinal system diseases (7%, 9). Cardiac causes are non ST-segment elevation myocardial infarction (NSTMI), arrhythmia, ST-segment elevation myocardial infarction (STEMI) and unstable angina pectoris (USAP), respectively. Troponin value was higher in patients with cardiac chest pain (p=0.02), and ferritin value was higher in patients with pneumonia (p=0.01). Conclusions: Chest pain or chest tightness is common in patients with active COVID-19. Although the causes of chest pain are due to musculoskeletal pathologies, both COVID-19 and cardiac origin chest pains due to direct cardiovascular system pathologies should be kept in mind.
No takes yet. Share an insight, caveat, or question.
Yasemin Doğan (2023) conducted an observational in COVID-19 with chest pain (n=102). COVID-19 was evaluated on Causes of chest pain. Among COVID-19 patients presenting to the emergency department with chest pain, the most common causes were musculoskeletal (39.2%), respiratory (23.5%), and cardiovascular (20.6%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: